Dr Zhao Defeng

Director - Hematology department , Experience: 24 Years

Book Appointment

About Doctor

Dr. Zhao Defeng is the Director of the Hematology Department at Gaobo Medical (Hematology) Beijing Research Center, Beijing Gaobo Boren Hospital, specializing in general hematology in Ward Nine. He holds the position of Associate Chief Physician and has a Master’s degree from the Second Military Medical University. Dr. Defeng has experience of over 1000 patients administering CAR T-Cell therapy and has more than 23 ongoing clinical trials on it. He is regarded as among the best doctor for CAR T-Cell therapy in China.

Graduating from the Second Military Medical University, Dr. Zhao has been engaged in clinical work in hematology for over 20 years and has published more than ten papers in both Chinese and English. He is skilled in diagnosing and treating various types of anemia, acute and chronic leukemia, lymphoma, and multiple myeloma, among other hematologic diseases. Dr. Zhao has extensive experience in the diagnosis and treatment of refractory and recurrent leukemia and lymphoma. He stays abreast of the latest developments in hematology, both internationally and domestically. Dr. Zhao excels in CAR-T cell therapy and comprehensive treatment, primarily focused on immunotargeting for leukemia, lymphoma, and multiple myeloma.


Beijing Gobroad Boren Hospital, China


  • Leukemia
  • Multiple Myeloma
  • Lymphoma
  • Hematological malignancies

Procedures Performed

  • CAR T-Cell therapy
  • Bone marrow transplant
  • TIL therapy
  • Cilta Cel therapy

Research & Publications

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy